Mapping Pathology as a Guide to Focal Therapy The Role of Mapping Biopsies and Tissue Markers

M. Scott Lucia, MD, discusses patient selection for targeted focal therapy (TFT) for prostate cancer, methods for accurately assessing tumors, as well as a pathological approach to monitoring the efficacy of TFT. Specifically, he reviews the accuracy of transperineal template-guided mapping biopsies (TTMB), Multiparametric MRI (mpMRI), and biomarkers.